Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.
暂无分享,去创建一个
A. Folsom | F. Nieto | P. McGovern | C. E. Davis | J. Eckfeldt | M. Malinow | D. Hess | M. Tsai | John | M. René Malinow | H. Eckfeldt | C. Davis | F. Nieto | David L. Hess | M. Malinow | A. Folsom | Michael Y. Tsai | Paul G. McGovern | C. E. Davis
[1] S. Wannamethee,et al. Measuring the Prevalence of Disease in Middle-aged British Men , 1999, Journal of the Royal College of Physicians of London.
[2] J. Manson,et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. , 1998, JAMA.
[3] S. Vollset,et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. , 1997, The New England journal of medicine.
[4] K. Woo,et al. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. , 1997, Circulation.
[5] J. Cutler,et al. Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[6] J. Witteman,et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. , 1997, JAMA.
[7] J. Witteman,et al. Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[8] Y. Yazaki,et al. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. , 1997, Circulation.
[9] W. Willett,et al. Plasma total homocysteine and risk of angina pectoris with subsequent coronary artery bypass surgery. , 1997, The American journal of cardiology.
[10] S. Vasikaran,et al. Methylenetetrahydrofolate reductase gene and coronary artery disease. , 1997, Circulation.
[11] L. Taylor,et al. Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease. , 1996, Circulation.
[12] M. Tsai,et al. High prevalence of a mutation in the cystathionine beta-synthase gene. , 1996, American journal of human genetics.
[13] W. Willett,et al. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. , 1996, Circulation.
[14] A. Evans,et al. Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation. , 1996, Circulation.
[15] J. Buring,et al. Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction. A case-control study. , 1996, Circulation.
[16] M. Tsai,et al. Simultaneous detection and screening of T833C and G919A mutations of the cystathionine beta-synthase gene by single-strand conformational polymorphism. , 1996, Clinical biochemistry.
[17] N. Key,et al. Molecular and biochemical approaches in the identification of heterozygotes for homocystinuria. , 1996, Atherosclerosis.
[18] H. Morrison,et al. Serum folate and risk of fatal coronary heart disease. , 1996, JAMA.
[19] R. Morris,et al. Serum total homocysteine and coronary heart disease in middle-aged , 1996 .
[20] W C Willett,et al. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. , 1996, American journal of epidemiology.
[21] W. Willett,et al. A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians. , 1996, Journal of the American College of Nutrition.
[22] A. Folsom,et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. , 1996, Journal of clinical epidemiology.
[23] M. Weijenberg. Prospective studies on coronary heart disease in the elderly : the role of classical and new risk factors , 1996 .
[24] David P Miller,et al. Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. , 1995, Circulation.
[25] G. Omenn,et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.
[26] K. Bønaa,et al. Serum total homocysteine and coronary heart disease. , 1995, International journal of epidemiology.
[27] J. Selhub,et al. Homocysteine and coronary artery disease in French Canadian subjects: relation with vitamins B12, B6, pyridoxal phosphate, and folate. , 1995, The American journal of cardiology.
[28] A. Lindgren,et al. Plasma homocysteine in acute myocardial infarction: homocysteine‐lowering effect of folic acid , 1995, Journal of internal medicine.
[29] R. Matthews,et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.
[30] W. Barlow,et al. Robust variance estimation for the case-cohort design. , 1994, Biometrics.
[31] J. Salonen,et al. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. , 1994, Atherosclerosis.
[32] P. Wong,et al. Thermolabile Defect of Methylenetetrahydrofolate Reductase in Coronary Artery Disease , 1993, Circulation.
[33] L. Chambless,et al. The Atherosclerosis Risk in Communities Study: Carotid Artery Intimal‐Medial Wall Thickening and Plasma Homocyst(e)ine in Asymptomatic Adults , 1993 .
[34] L. Chambless,et al. Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study. , 1993, Circulation.
[35] W. Willett,et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. , 1992, JAMA.
[36] G. Heller,et al. Comparison of "Rose Questionnaire Angina" to exercise thallium scintigraphy: different findings in males and females. , 1992, Journal of clinical epidemiology.
[37] L. Chambless,et al. High‐Resolution B‐Mode Ultrasound Reading Methods in the Atherosclerosis Risk in Communities (ARIC) Cohort , 1991, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[38] George Howard,et al. High‐resolution B‐Mode Ultrasound Scanning Methods in the Atherosclerosis Risk in Communities Study (ARIC) , 1991, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[39] M. Malinow,et al. Homocyst(e)inemia in daily practice: levels in coronary artery disease , 1990 .
[40] Aric Invest. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators , 1989 .
[41] L. Taylor,et al. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. , 1989, Circulation.
[42] A. Folsom,et al. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.
[43] Shirley A. Miller,et al. A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.
[44] L. A. Smolin,et al. Measurement of total plasma cysteamine using high-performance liquid chromatography with electrochemical detection. , 1988, Analytical biochemistry.
[45] W. Willett,et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. , 1985, American journal of epidemiology.
[46] W. Gruber,et al. Reagent for the Enzymatic Determination of Serum Total Triglycerides with Improved Lipolytic Efficiency , 1984, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.
[47] J. Ziegenhorn,et al. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. , 1983, Clinical chemistry.
[48] J E Frijters,et al. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. , 1982, The American journal of clinical nutrition.
[49] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.
[50] H. Blackburn,et al. Cardiovascular survey methods. , 1969, Monograph series. World Health Organization.
[51] A. Clauss,et al. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens , 1957 .
[52] C. Dolea,et al. World Health Organization , 1949, International Organization.
[53] Agricultural University, , 2022 .